Skip to main content
GLAONS Survey of Oncology Nurses Reveals Knowledge Gap Regarding Novel Treatment Options
Lyn Brook
Practice Patterns
In September 2022, i3 Health conducted a survey of 157 oncology nurses at the Greater Los Angeles Oncology Nursing Society (GLAONS) 6th Annual Oncology Care Summit to assess nurses' familiarity with and desire to understand novel oncology treatment options, including chimeric antigen receptor (CAR) T-cell therapies, cyclin-dependent kinase (CDK)4/6...
GLAONS Survey of Oncology Nurses Reveals Knowledge Gap Regarding Genetic Evaluation and LGBTQIA+ Cancer Care
Lyn Brook
GLAONS Interviews
In September 2022, i3 Health conducted a survey of 157 oncology nurses at the Greater Los Angeles Oncology Nursing Society (GLAONS) 6th Annual Oncology Care Summit to assess nurses' familiarity with and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Through genetic evaluation and counseling care, patients can bette...
Keeping Abreast of Pharmacological Developments in Cancer Care: Perspectives from Teresa Knoop, MSN, RN, AOCN®
Selma Khenissi, MPS
Expert Analysis
Teresa Knoop, MSN, RN, AOCN®. At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Teresa Knoop, MSN, RN, AOCN® gave a presentation on updates surrounding pharmacology. Oncology Data Advisor followed up with her, asking for advice on how to provide optimal pharmacological care for patients with cancer. 
Managing the Care of Patients With Renal Cell Carcinoma During the COVID-19 Pandemic: Advice from Nazy Zomorodian, RNC, MSN, CUNP, CCRC
Sarah Williams, MAT
Expert Analysis
Nazy Zomorodian, RNC, MSN, CUNP, CCRC. At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Nazy Zomorodian, NP, a nurse practitioner in the Department of Urology at the University of California Los Angeles (UCLA) Medical Center, about strategies for optimizing patient experiences during renal cell carcinoma treatment. Ms. Zomorodian discusses the challenges of treating patients with renal cell carcinoma, particularly during the COVID-19 pandemic, and shares strategies for promoting adherence and optimizing treatment outcomes.
Improving Patient Experiences in Multiple Myeloma With Tiffany Richards, PhD, ANP-BC
Sarah Williams, MAT
Expert Analysis
At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Tiffany Richards, PhD, ANP-BC, Advanced Practice Nurse at MD Anderson Cancer Center, about strategies for optimizing patient experiences during multiple myeloma treatment. Dr. Richards discusses the challeng...